KB
Kelly Brady
DELAYED 1 MONTH
Chief Operating Officer, EVP
Seres Therapeutics, Inc.
Filings
2
Companies
1
Latest
May 15, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
67
MCRBCLUSTER 4
Seres Therapeutics, Inc.
Kelly Brady
Chief Operating Officer, EVP
Sale
$444
59 sh
May 19 8:05 PM
May 18, 2026
—
Seres Therapeutics, Inc.
Kelly Brady
Chief Operating Officer, EVP
Option Exercise
—
180 sh
May 19 8:05 PM
May 15, 2026